Create Account
Sign In
Dark
chart
exchange
Terminal
Screener
Stocks
Crypto
Forex
Watchlists
Trends

MRK
Merck & Co Inc
stock NYSE

At Close
2/3/2023 3:59:57 PM EST
102.92USD-0.522%(-0.54)11,210,818
101.01Bid   105.19Ask   4.18Spread IEX
Pre-market
2/3/2023 9:21:30 AM EST
103.46USD0.000%(0.00)0
After-hours
2/3/2023 4:02:34 PM EST
102.94USD+0.019%(+0.02)0
OverviewOption ChainHistoricalExchange VolumeShort VolumeBorrow FeeFailure to DeliverTrendsNewsMore
open chart   
open chart   
Market Cap
260.943B
CEO
Kenneth Frazier
Headquarters
Kenilworth, New Jersey, USA
Industry
Drug Manufacturers-General
Last Dividend
2022-12-140.730
Last Split
1999-02-172for1
Related
AMGNGSKNVSBMYJNJLLYPFESNYTEVAXLV
MRK Stats
Avg. Vol. 10 Day
7,938,355
Avg. Vol. 30 Day
8,739,398
Dividend Yield
2.589%
Dividend Rate (ttm)
2.770
Next Dividend Date
2023-03-14
Employees
67,000
Market Cap
260,942,953,644
Shares Out.
2,535,395,974
Float
2,532,099,959
P/E Ratio
17.77
EPS (ttm)
6.080
On/Off Exchange
63%/37%
6 Month Beta
0.27
1 Year Beta
0.28
2 Year Beta
0.26
3 Year Beta
0.52
52 Week Low
70.61
52 Week High
115.49
SMA50
110.12
SMA200
97.33
1 Week
-2.99%
1 Month
-9.43%
3 Month
+3.75%
6 Month
+18.03%
1 Year
+31.01%
2 Year
+35.78%
5 Year
+82.48%
Jan 31, 2022
09:49AM EST  Price To Earnings Ratio Insights For Merck & Co   Benzinga
Jan 28, 2022
02:03PM EST  Analyst Ratings For Merck & Co   Benzinga
11:00AM EST  Merck's COVID-19 Pill works Against Omicron, Lab Studies Show   Benzinga
08:58AM EST  Merck (MRK) and Ridgeback Biotherapeutics reported data from six preclinical studies showing that molnupiravir, an investigational oral antiviral COVID-19 medicine, was active against the Omicron variant in In Vitro studies. The in vitro studies were independently conducted by researchers from institutions in six countries.   RTTNews
08:49AM EST  Merck's Molnupiravir, COVID-19 Medicine, Shows Activity Against Omicron Variant In Vitro Studies   RTTNews
More News
Profile
For 130 years, Merck, known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases in pursuit of its mission to save and improve lives. It demonstrates its commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to prevent and treat diseases that threaten people and animals - including cancer, infectious diseases such as HIV and Ebola, and emerging animal diseases - as we aspire to be the premier research-intensive biopharmaceutical company in the world.

MRK Stock Summary

Merck & Co Inc (NYSE:MRK) stock price today is $102.92, and today's volume is 11,210,818. MRK is down -0.522% today. The 30 day average volume is 8,739,398. MRK market cap is 260.943B with 2,535,395,974 shares outstanding.



Share
About
Symbol List

Pricing
Disclaimer

ChartExchange on Twitter
ChartExchange on Reddit
© 2020 - 2023 ChartExchange LLC